Risperidone for the treatment of fecal smearing in a developmentally disabled adult

American Journal of Health-System Pharmacy

Volumn 64, Issue 4, 2007, Pages 382-384

  Brahm, Nancy C ^a   Farmer, Kevin C ^a   Brown, Robert C ^a,b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b Oklahoma DHS Developmental Disabilities Services Division   (United States)

Author keywords

Aggression; Antipsychotic agents; Dosage; Mental retardation; Risperidone

Indexed keywords

ALPHA TOCOPHEROL; HALOPERIDOL; NALTREXONE; RISPERIDONE; TRAZODONE; VALPROIC ACID;

ADULT; AGGRESSION; ARTICLE; AUTISM; BEHAVIOR DISORDER; CASE REPORT; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; FECAL SMEARING; FOLLOW UP; HEPATITIS A; HEPATITIS B; HUMAN; INTELLIGENCE QUOTIENT; MALE; MENTAL DEFICIENCY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYMPTOM;

EID: 33847162170     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060176     Document Type: Article

References (12)

1. Rush KS, Bowman LG, Eidman SL et al. Assessing psychopathology in individuals with developmental disabilities. Behav Modif. 2004; 28:621-37.
2. Gualtieri CT. Brain injury and mental retardation: psychopharmacology and neuropsychiatry. Philadelphia: Lippincott Williams and Wilkins; 2002:175-84.
3. Dartnall NA, Holmes JP, Morgan SN et al. Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism. J Autism Dev Disord. 1999; 29:87-91.
4. Hardan A, Johnson K, Johnson C et al. Case study: risperidone treatment of children and adolescents with developmental disorders. J Am Acad Child Adolesc Psychiatry. 1996; 35:1551-6.
5. Schreier HA. Risperidone for young children with mood disorders and aggressive behavior. J Child Adolesc Psychopharmacol. 1998; 8:49-59.
6. Sprague RL, Kalachnik JE. Reliability, validity, and a total score cutoff for the Dyskinesia Identification System: Condensed User Scale (DISCUS) with mentally ill and mentally retarded populations. Psychopharmcol Bull. 1991; 27:51-8.
7. Risperdal (risperidone) product information. Titusville, NJ: Janssen Pharmaceutica; 2004.
8. Schloss P, Williams DC. The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol. 1998; 12:115-21.
9. Lott RS, Kerrick JM, Cohen SA. Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance. Psychopharmacol Bull. 1996; 32:721-9.
10. Horrigan JP, Barnhill LJ. Risperidone and explosive aggressive autism. J Autism Dev Disord. 1997; 27:313-23.
11. Friedin BD, Johnson HK. Treatment of a retarded child's faeces smearing and coprophagic behaviour. J Ment Defic Res. 1979; 23:55-61.
12. Khan BU. Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults. J Autism Dev Disord. 1997; 27:479-89.